Magdy El‐Serafy

972 total citations
39 papers, 438 citations indexed

About

Magdy El‐Serafy is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Magdy El‐Serafy has authored 39 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 30 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Magdy El‐Serafy's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (26 papers) and Hepatitis B Virus Studies (14 papers). Magdy El‐Serafy is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (26 papers) and Hepatitis B Virus Studies (14 papers). Magdy El‐Serafy collaborates with scholars based in Egypt, United States and France. Magdy El‐Serafy's co-authors include Gamal Esmat, Wahid Doss, Manal H. El‐Sayed, Mohamed Hassany, Wafaa Elakel, Imam Waked, Kadry Elsaeed, Mohamed Shaker, Mohamed El‐Kassas and A. Yosry and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Hepatology.

In The Last Decade

Magdy El‐Serafy

35 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdy El‐Serafy Egypt 10 354 312 49 41 29 39 438
Rikita Hatia United States 8 254 0.7× 254 0.8× 32 0.7× 27 0.7× 36 1.2× 18 345
Angie Price United States 8 394 1.1× 341 1.1× 39 0.8× 9 0.2× 69 2.4× 13 498
Baris Deniz United States 10 249 0.7× 245 0.8× 36 0.7× 8 0.2× 35 1.2× 25 412
A. Abdo Saudi Arabia 11 303 0.9× 322 1.0× 17 0.3× 14 0.3× 20 0.7× 25 431
Jun Hiramoto Japan 5 268 0.8× 198 0.6× 31 0.6× 9 0.2× 16 0.6× 10 335
Lóa Davíðsdóttir Sweden 8 348 1.0× 397 1.3× 23 0.5× 11 0.3× 12 0.4× 12 495
Takeaki Satoh Japan 13 560 1.6× 515 1.7× 50 1.0× 16 0.4× 78 2.7× 35 624
Giulia Troshina Italy 10 177 0.5× 138 0.4× 39 0.8× 17 0.4× 51 1.8× 16 227
F. Nevens Belgium 6 121 0.3× 138 0.4× 26 0.5× 24 0.6× 18 0.6× 9 209
Marta Wawrzynowicz‐Syczewska Poland 10 225 0.6× 211 0.7× 30 0.6× 5 0.1× 37 1.3× 46 373

Countries citing papers authored by Magdy El‐Serafy

Since Specialization
Citations

This map shows the geographic impact of Magdy El‐Serafy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdy El‐Serafy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdy El‐Serafy more than expected).

Fields of papers citing papers by Magdy El‐Serafy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdy El‐Serafy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdy El‐Serafy. The network helps show where Magdy El‐Serafy may publish in the future.

Co-authorship network of co-authors of Magdy El‐Serafy

This figure shows the co-authorship network connecting the top 25 collaborators of Magdy El‐Serafy. A scholar is included among the top collaborators of Magdy El‐Serafy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdy El‐Serafy. Magdy El‐Serafy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Kassas, Mohamed, Wafaa Elakel, Aisha Elsharkawy, et al.. (2024). Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients. Scientific Reports. 14(1). 29544–29544. 1 indexed citations
2.
El‐Serafy, Magdy, Maissa El Raziky, Wafaa Elakel, et al.. (2023). Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease. Arab Journal of Gastroenterology. 24(1). 29–33.
3.
Hassany, Mohamed, Wafaa Elakel, Mohamed AbdAllah, et al.. (2022). Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt. Arab Journal of Gastroenterology. 23(4). 259–262. 3 indexed citations
4.
Zayed, Naglaa, et al.. (2021). Inter-method variability of hepatitis B surface antigen quantification in a cohort of Egyptian patients with chronic hepatitis B virus. Arab Journal of Gastroenterology. 22(2). 151–157. 2 indexed citations
5.
Mostafa, Aya, Ossama Ashraf Ahmed, Hany Dabbous, et al.. (2021). The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting. VirusDisease. 32(3). 582–588. 1 indexed citations
6.
Abdel‐Razek, Wael, Mohamed Hassany, Manal H. El‐Sayed, et al.. (2019). Hepatitis C Virus in Egypt: Interim Report From the World’s Largest National Program. Clinical Liver Disease. 14(6). 203–206. 18 indexed citations
7.
El‐Serafy, Magdy, Marwa Salama, Ehab Kamal, et al.. (2019). Sofosbuvir‐containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment. Liver International. 40(4). 797–805. 15 indexed citations
8.
Said, Mohamed, et al.. (2018). High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy. Hepatology International. 12(2). 143–148. 3 indexed citations
9.
El‐Kassas, Mohamed, Dalia Omran, Kadry Elsaeed, et al.. (2018). Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 38(2). 81–85. 5 indexed citations
10.
11.
Yosry, Ayman, Eman Medhat, Naglaa Zayed, et al.. (2018). Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience. Journal of Medical Virology. 91(4). 668–676. 2 indexed citations
12.
Elbaz, Tamer, Magdy El‐Serafy, Wafaa Elakel, et al.. (2017). Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 37(8). 348–353. 4 indexed citations
13.
Elsharkawy, Aisha, Maissa El Raziky, Wafaa Elakel, et al.. (2017). Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience. Journal of Hepatology. 68(4). 691–698. 50 indexed citations
14.
Elakel, Wafaa, Manal H. El‐Sayed, Mohamed El‐Kassas, et al.. (2017). National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care. Journal of Viral Hepatitis. 24(4). 262–267. 140 indexed citations
15.
Saad, Yasmin, et al.. (2013). New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.. PubMed. 22(4). 419–25. 16 indexed citations
16.
El‐Serafy, Magdy, et al.. (2012). The combination of endoglin and FIB-4 increases the accuracy of detection of hepatic fibrosis in chronic hepatitis C patients. Open Journal of Gastroenterology. 2(2). 62–67. 1 indexed citations
17.
Hamdi, Nabila, Wafaa Elakel, Magdy El‐Serafy, et al.. (2011). Transcriptional Response of MxA, PKR and SOCS3 to Interferon-Based Therapy in HCV Genotype 4-Infected Patients and Contribution of p53 to Host Antiviral Response. Intervirology. 55(3). 210–218. 9 indexed citations
18.
Yosry, Ayman, Gamal Esmat, Magdy El‐Serafy, et al.. (2009). Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.. PubMed. 7(3). 157–63. 10 indexed citations
19.
Yosry, A., Gamal Esmat, Magdy El‐Serafy, et al.. (2008). Outcome of Living Donor Liver Transplantation for Egyptian Patients With Hepatitis C (Genotype 4)-Related Cirrhosis. Transplantation Proceedings. 40(5). 1481–1484. 9 indexed citations
20.
El-Karaksy, Hanaa, et al.. (2007). Equal outcome of living-related liver transplantation for <i>Wilson's disease</i> from heterozygote and nonheterozygote donors: A report of a brother and sister. Indian Journal of Medical Sciences. 61(5). 286–286. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rikita Hatia Breakdown of academic impact, for papers by Angie Price Breakdown of academic impact, for papers by Baris Deniz Breakdown of academic impact, for papers by A. Abdo Breakdown of academic impact, for papers by Jun Hiramoto Breakdown of academic impact, for papers by Lóa Davíðsdóttir Breakdown of academic impact, for papers by Takeaki Satoh Breakdown of academic impact, for papers by Giulia Troshina Breakdown of academic impact, for papers by F. Nevens Breakdown of academic impact, for papers by Marta Wawrzynowicz‐Syczewska
Rankless by CCL
2026